IMMUNOSTAD invalidation appeal dismissed
The First Chamber of the General Court recently dismissed an appeal brought by Stada Arzneimittel AG against the EU Intellectual Property Office Board of Appeal’s decision to invalidate the mark IMMUNOSTAD for goods in Class 5.
To read more
Register for limited access
Register to receive our newsletter and gain limited access to subscriber content.
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the WTR experts.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10